CAS: 1026295-98-6
L-Lysinamide, N-acetyl-L-leucylglycyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-N6-(2,2,2-trifluoroacetyl)-
CAS:1026295-98-6
Formula:
C28H36F3N5O7
Molecular weight:
611.6099
Ref: IN-DA0007YY
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 12 Nov 2024
(S)-2-(2-((S)-2-Acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)-6-(2,2,2-trifluoroacetamido)hexanamide
CAS:1026295-98-6
Please enquire for more information about (S)-2-(2-((S)-2-Acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)-6-(2,2,2-trifluoroacetamido)hexanamide including the price, delivery time and more detailed …
Formula:
C28H36F3N5O7
Purity:
Min. 95%
Molecular weight:
611.61 g/mol
Ref: 3D-BRB29598
| 250mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
HDAC-IN-6
CAS:1026295-98-6
HDAC-IN-6 is an HDAC inhibitor, targeting HDAC2, HDAC3, HDAC4, HDAC5, HDAC7, HDAC8, and HDAC9.
Formula:
C28H36F3N5O7
Color and Shape:
Solid
Molecular weight:
611.61
Ref: TM-T72012
| 25mg | 1,796.00 € | ||
| 50mg | 2,352.00 € | ||
| 100mg | 3,100.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
